Blood Ropivacaine Concentrations Following Paravertebral Nerve Block and Continuous Infusion in Infants and Toddlers Undergoing Staged Esophageal Atresia Repair

Trial Profile

Blood Ropivacaine Concentrations Following Paravertebral Nerve Block and Continuous Infusion in Infants and Toddlers Undergoing Staged Esophageal Atresia Repair

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 16 Nov 2017

At a glance

  • Drugs Ropivacaine (Primary)
  • Indications Postoperative pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 Nov 2017 Planned End Date changed from 1 Aug 2017 to 1 Aug 2018.
    • 09 Nov 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Aug 2018.
    • 09 Nov 2017 Planned initiation date changed from 1 Jun 2017 to 1 Jan 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top